Quest Diagnostics Genetic Insights At-Home Genetic Health Test User Guide
- June 12, 2024
- Quest Diagnostics
Table of Contents
Genetic Insights: quick reference guide for healthcare providers
This guide is intended to facilitate a discussion between a provider and their
patient.
Genetic Insights test results: Familial hypercholesterolemia
Key results
A pathogenic or likely pathogenic variant associated with familial
hypercholesterolemia was found in the APOB gene.
People with familial hypercholesterolemia have very high levels of LDL
cholesterol which leads to an increased risk of cardiovascular disease.
Next steps
Clinical recommendations | Resources |
---|
Genetic Insights is a screening test and not intended for diagnosis.
A cholesterol test to check for elevated LDL and total cholesterol levels for
correlation of this result is indicated.
Follow-up genetic testing may also be indicated if medical management would be
impacted.| Ready to order?
Check with your institution and/or patient’s insurance about the preferred
testing laboratory.
Quest Diagnostics® offers cholesterol testing through your EHR or from the
Quest online Test
Directory
Blueprint Genetics® offers familial hypercholesterolemia genetic testing. To
confirm this test result, targeted variant testing for the variant identified
is available. You can order a confirmation test here: Blueprint
Genetics/TVT
Have questions?
Call 1.866.GENE.INFO (1.866.436.3463) to speak to a specialized Quest genetic
counselor or geneticist available to healthcare providers to discuss test
selection and results.
Refer your patient to a genetic counselor specializing in familial
hypercholesterolemia.
Genetic counselors can provide counseling on the implications of this test
result and next steps for your patient.| Your patient can schedule a 1-on-1
remote genetic counseling session through their online Genetic Insights
Familial Hypercholesterolemia Report at no additional cost.
To find a genetic counselor with expertise in familial hypercholesterolemia
practicing in your patient’s area for an in-person session, please visit
FindAGeneticCounselor.NSGC.org
Patient conversation starters:
Patient conversation starters summarize the preceding information in plain
language to support meaningful conversations between you and your patient.
FindAGeneticCounselor.NSGC.org
Your Genetic Insights test is a screening test. The next step is to confirm
your result with a second test, such as a cholesterol test to see if your
cholesterol level is high.
It’s also important that you talk with a genetic counselor. Genetic counselors
are experts in genetics and can help you understand this result and potential
next steps.
You can access a genetic counselor through your Genetic Insights dashboard at
no additional cost to you, and we can discuss a referral to a local genetic
counselor.
Visit QuestDiagnostics.com/Genetic-Health- Screening for more information about this test.
What is familial hypercholesterolemia?
Familial hypercholesterolemia (FH) is a genetic condition characterized by
LDL-C cholesterol levels typically above 190 mg/dL and/or total cholesterol
greater than 310 mg/dL.1,2 This is associated with an increased risk for
premature coronary artery disease and heart attack.1,2
Males with FH who are untreated have about a 50% risk for a coronary event by
age 50. Females with untreated FH are at a 30% risk for the same by age 60.2
Treatment is based on LDL cholesterol levels including aggressive
pharmacological management.1,2
See the Management options section for more detail.
Patient conversation starters:
Familial hypercholesterolemia (called FH for short) causes very high levels of
the form of cholesterol called LDL cholesterol. Left untreated, these high
levels increase the chance of having a heart attack or other serious heart
problems.
Most of the time for people with FH, diet and lifestyle changes are not enough
to lower cholesterol levels. Most people need to take medication to help stay
healthy.
What this result means for family members
Family members may have the same DNA variant. The DNA variant was most likely
inherited from a parent.
Full siblings and children have a 50% chance of having this variant.
In people with a confirmed DNA variant associated with FH, cascade genetic
testing for other family members may help inform their risks and screening
protocols.
A genetic counselor can help determine the most appropriate testing options.
Therefore, it is strongly recommended that people share their results with
their biological relatives.
Patient conversation starters:
FH runs in families.
That means the DNA variants that cause FH can be inherited or passed down from
parents to their children. Your close relatives, like your parents, full
siblings, and children have a 50% (or 1 in 2) chance of having the same DNA
variant.
Other relatives might also have the same DNA variant.
Sharing these results with your family is important so family members can
decide if they want to have genetic testing for FH.
Management options
There are options for management for people with FH. Clinical guidelines from the American Heart Association1 include:
For adults with FH
For individuals with increased cholesterol, high-intensity statin therapy to
achieve LDL cholesterol reduction of greater than or equal to 50% is critical
Individuals with FH require treatment of associated cardiovascular risk
factors, including obesity, hypertension, diabetes mellitus, and tobacco use
Cascade lipid screening of first-degree relatives should be offered; genetic
testing for a known familial DNA variant associated with FH can clarify the
necessity for accelerated screening recommendations
Other clinical, treatment, and management considerations are required for:
- Children
- Women of childbearing age or who are pregnant
- Individuals nonresponsive to statins or where statins are contraindicated
- Individuals who may be candidates for LDL apheresis
Patient conversation starters:
People with FH need to get the right treatment. Most of the time, people with
FH need to take medication to lower their cholesterol levels and help prevent
a heart attack. It’s important to work with the right FH specialist to make a
treatment plan.
Refer to current guidelines for complete recommendations. Guidelines and
recommendations may change over time.
Local centers for excellence in FH should be consulted for further clinical
management. Search the FH Foundation’s website and locate a specialist for
your patient.
Additional resources
The following advocacy groups have additional information and resources about
FH:
The FH Foundation: TheFHFoundation.org
The American Heart Association: Heart.org
References
- Gid ding SS, Champagne MA, et al. The Agenda for Familial Hypercholesterolemia: A Scientific Statement From the American Heart Association. Circulation. 2015;132(22):2167-2192. https://www.ncbi.nlm.nih.gov/pubmed/26510694
- Ison HE, Clarke SL, Knowles JW. Familial Hypercholesterolemia. January 2, 2014. Updated July 7, 2022. In: Adam MP, Ardinger HH, Pagon RA, et al, editors. Gene Reviews®. University of Washington, Seattle; 1993-2023. https://www.ncbi.nlm.nih.gov/books/NBK174884
This information is not a substitute for medical advice, diagnosis, or
treatment. The diagnosis or treatment of any disease or condition may be based
on personal history, family history, symptoms, a physical examination,
laboratory test results, and other information considered important by a
healthcare provider.
Individuals should talk with a healthcare provider about the meaning of
genetic test results and before stopping, starting, or changing any medication
or treatment.
Genetic Insights is a test developed and performed by Quest Diagnostics. The
test results are not diagnostic and do not determine overall chances of
developing a disease or health condition. The tests are not cleared or
approved by the US Food and Drug Administration.
QuestDiagnostics.com
Quest, Quest Diagnostics, any associated logos, and all associated Quest
Diagnostics registered or unregistered trademarks are the property of Quest
Diagnostics.
All third-party marks—® and ™—are the property of their respective owners. ©
2023 Quest Diagnostics Incorporated. All rights reserved. MI11993 4/2023
References
- Targeted Variant Testing - Blueprint Genetics
- Colorectal Cancer Alliance | Prevention, Research, Patient Support | Colorectal Cancer Alliance
- FORCE - Facing Hereditary Cancer Empowered home page
- Fight Colorectal Cancer | Relentless Champions of Hope
- Home
- American Heart Association | To be a relentless force for a world of longer, healthier lives
- Home | Quest Diagnostics
- Genetic health screening | Quest Diagnostics
- Family Heart Organization - Family Heart Foundation
- American Heart Association | To be a relentless force for a world of longer, healthier lives
- Family Heart Organization - Family Heart Foundation
- Fight Colorectal Cancer | Relentless Champions of Hope
- Hemochromatosis.org - An Education Website for Hemochromatosis and Too Much Iron | Educate yourself about Hemochromatosis, a genetic condition of iron metabolism
- Colorectal Cancer — Cancer Stat Facts
- Quest Diagnostics: Test Directory
- Colorectal Cancer Alliance | Prevention, Research, Patient Support | Colorectal Cancer Alliance
- FORCE - Facing Hereditary Cancer Empowered home page
- Familial Hypercholesterolemia - GeneReviews® - NCBI Bookshelf
- The Agenda for Familial Hypercholesterolemia: A Scientific Statement From the American Heart Association - PubMed